Dynavax Technologies Corp (DVAX)

15.43
NASDAQ : Health Care
Prev Close 15.50
Day Low/High 15.14 / 15.59
52 Wk Low/High 12.84 / 32.49
Avg Volume 609.10K
Exchange NASDAQ
Shares Outstanding 38.50M
Market Cap 596.68M
EPS -3.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Commit To Purchase Dynavax Technologies Corp At $12, Earn 35.7% Annualized Using Options

Commit To Purchase Dynavax Technologies Corp At $12, Earn 35.7% Annualized Using Options

Investors considering a purchase of Dynavax Technologies Corp stock, but cautious about paying the going market price of $14.81/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2017 put at the $12 strike, which has a bid at the time of this writing of $2.50.

DVAX: Insiders Vs. Shorts

DVAX: Insiders Vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and Dynavax Technologies Corp is one of the most shorted stocks of the Russell 3000, based on 7.84 "days to cover" versus the median component at 5.75. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Perilous Reversal Stock: Dynavax Technologies (DVAX)

Perilous Reversal Stock: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a "perilous reversal" (up big yesterday but down big today) candidate

Dynavax Technologies Enters Oversold Territory (DVAX)

Dynavax Technologies Enters Oversold Territory (DVAX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

4 Possible Biotech M&A Targets

These concerns are well on their way to FDA approval for their first commercialized products in addressable markets.

Today's Pre-Market Mover With Heavy Volume: Dynavax Technologies (DVAX)

Today's Pre-Market Mover With Heavy Volume: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a pre-market mover with heavy volume candidate

Strong On High Volume: Dynavax Technologies (DVAX)

Strong On High Volume: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a strong on high relative volume candidate

M&A Could Ignite Next Leg Up for Biotech

Pharma and biotech giants now must look to small- and mid-caps to fill out pipelines and bolster growth.

'Mad Money' Lightning Round: Take Lockheed Martin Over Boeing

'Mad Money' Lightning Round: Take Lockheed Martin Over Boeing

Cramer is not crazy about J.C. Penney and he's not buying AK Steel.

Jim Cramer's 'Mad Money' Recap: Be Brave, Keep Investing in Stocks

Jim Cramer's 'Mad Money' Recap: Be Brave, Keep Investing in Stocks

Don't let the talk of bubbles in the stock market scare you, Cramer says. The market is still the best game in town.

Here's Why Dynavax Technologies (DVAX) Stock is Climbing Today

Here's Why Dynavax Technologies (DVAX) Stock is Climbing Today

Dynavax Technologies (DVAX) stock is rising as the FDA accepted for review the company's vaccine candidate for immunization against hepatitis B infection in adults 18 years and up.

Revisiting 3 Promising Small Biotechs

They are oversold and lately been on the move.

Interesting DVAX Put And Call Options For May 20th

Interesting DVAX Put And Call Options For May 20th

Investors in Dynavax Technologies Corp saw new options begin trading this week, for the May 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX options chain for the new May 20th contracts and identified one put and one call contract of particular interest.

A Small Biotech Sells for Less Than Cash

And yet, Endocyte has a deep pipeline.

Biotech Stocks Are Beginning to Stir

I am starting to get more confident that the small caps are ready to bounce.

Dynavax Technologies (DVAX) Weak On High Volume

Dynavax Technologies (DVAX) Weak On High Volume

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a weak on high relative volume candidate

Dynavax Technologies Becomes Oversold (DVAX)

Dynavax Technologies Becomes Oversold (DVAX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Storm The Castle Stock Of The Day: Dynavax Technologies (DVAX)

Storm The Castle Stock Of The Day: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate

Stock To Watch: Dynavax Technologies (DVAX) In Perilous Reversal

Stock To Watch: Dynavax Technologies (DVAX) In Perilous Reversal

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a "perilous reversal" (up big yesterday but down big today) candidate

Dynavax Technologies (DVAX) Shares Cross Above 200 DMA

Dynavax Technologies (DVAX) Shares Cross Above 200 DMA

In trading on Thursday, shares of Dynavax Technologies Corp crossed above their 200 day moving average of $24.98, changing hands as high as $28.14 per share. Dynavax Technologies Corp shares are currently trading up about 28.5% on the day.

Today's Pre-Market Mover With Heavy Volume: Dynavax Technologies (DVAX)

Today's Pre-Market Mover With Heavy Volume: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a pre-market mover with heavy volume candidate

Dynavax Technologies Becomes Oversold (DVAX)

Dynavax Technologies Becomes Oversold (DVAX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

JPMorgan Likes These 5 Biotech Stocks

JPMorgan Likes These 5 Biotech Stocks

Shares of biotech stocks have been volatile this year, but the sector is still outperforming the broader markets. Here's JPMorgan's top biotech picks coming out of earnings season.

First Week of December 18th Options Trading For Dynavax Technologies (DVAX)

First Week of December 18th Options Trading For Dynavax Technologies (DVAX)

Investors in Dynavax Technologies Corp saw new options begin trading this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX options chain for the new December 18th contracts and identified one put and one call contract of particular interest.

Dynavax Technologies Stock Sees Short Interest Decline 10%

Dynavax Technologies Stock Sees Short Interest Decline 10%

The most recent short interest data has been released by the NASDAQ for the 09/30/2015 settlement date, which shows a 405,985 share decrease in total short interest for Dynavax Technologies Corp , to 3,608,899, a decrease of 10.11% since 09/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Today's Weak On High Volume Stock: Dynavax Technologies (DVAX)

Today's Weak On High Volume Stock: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a weak on high relative volume candidate

First Week of DVAX November 20th Options Trading

First Week of DVAX November 20th Options Trading

Investors in Dynavax Technologies Corp saw new options become available this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX options chain for the new November 20th contracts and identified one put and one call contract of particular interest.

Today's Perilous Reversal Stock: Dynavax Technologies (DVAX)

Today's Perilous Reversal Stock: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a "perilous reversal" (up big yesterday but down big today) candidate